DENVER, Feb. 16, 2007 (PRIME NEWSWIRE) -- Avitech Lifesciences Inc. (Other OTC:AVLF) is providing all current shareholders with the company's 2006-2007 business summary and management agenda.
The letter will be an update of current activities and reflect on Avitech's accomplishments and enthusiasm. In a short period of time we have launched two e-commerce Internet sites showcasing our products. Under the product name of Aviessence and Avitol our sites can be accessed at: www.avi-essence.com and www.aviessence.com.
"We encourage everyone to visit us at these sites and share in our enthusiasm," stated Terry Miller, President and CEO.
About Avitech Lifesciences Inc.
Avitech Lifesciences Inc. is a firm focused on the health and life sciences industry. Avitech helps entrepreneurs accelerate their business development by investing early in the company's development and taking an active role in its day to day operations by acting as collaborative partners with the companies we bring on board. Although Avitech Lifesciences Inc. primary mandate is the health and life sciences sector, the company's mandate will allow it to look at all investments to increase shareholder value.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.